原发性甲状旁腺功能亢进与甲状腺疾病术前影像不一致时的选择
该单中心回顾性研究纳入112例成功行甲状旁腺切除术的原发性甲状旁腺功能亢进患者,比较sestamibi-高锝酸盐与超声的定位准确性;sestamibi灵敏度72%、阳性预测值90%,超声分别为50%、80%;甲状腺炎降低sestamibi准确性,影像侧别不一致时sestamibi总体更准确,但甲状腺炎患者超声更优。
要点
- sestamibi-高锝酸盐定位灵敏度72%、阳性预测值90%,优于超声的50%、80%。
- 甲状腺炎患者sestamibi灵敏度降至53%、阳性预测值77%,超声为54%、88%。
- 影像侧别不一致时sestamibi总体正确率53%,甲状腺炎患者仅17%,超声为50%。
核心结论
- 甲状腺炎降低sestamibi-高锝酸盐在原发性甲状旁腺功能亢进中的灵敏度和阳性预测值。
- 影像侧别不一致时sestamibi-高锝酸盐总体更准确,但甲状腺炎患者超声可能更优。
研究设计与样本
- 单中心回顾性研究,纳入112例连续的原发性甲状旁腺功能亢进患者,均成功行甲状旁腺切除术并接受sestamibi-高锝酸盐和超声检查。
主要发现
- sestamibi-高锝酸盐灵敏度72%、阳性预测值90%;超声灵敏度50%、阳性预测值80%。
- 甲状腺炎患者sestamibi-高锝酸盐灵敏度53%、阳性预测值77%;超声灵敏度54%、阳性预测值88%。
- 甲状腺结节患者中两种 modality 的灵敏度和阳性预测值无差异。
- 17例(15%)术前影像侧别不一致;不一致病例中sestamibi-高锝酸盐总体正确率53%,甲状腺炎患者仅17%(P = .01);超声总体正确率26%,甲状腺炎患者50%(P = .01)。
临床怎么用
- 术前影像侧别不一致时,可优先依据sestamibi-高锝酸盐规划手术。
- 合并甲状腺炎时,超声可能提供更准确的侧别定位。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preoperative localization of abnormal parathyroid glands in primary hyperparathyroidism is often obtained by sestamibi, and ultrasonography. We aimed to identify which modality is most accurate when laterality of abnormal glands on preoperative imaging is discordant. METHODS: A single institution retrospective review identified 112 consecutive patients with primary hyperparathyroidism who underwent successful parathyroidectomy and sestamibi with pertechnetate. RESULTS: Sestamibi with pertechnetate had a sensitivity of 72% and positive predictive value of 90%; ultrasonography had sensitivity of 50% and positive predictive value 80%. Patients with thyroiditis had lesser sensitivity and positive predictive value on sestamibi with pertechnetate (53% and 77%, respectively), in contrast to ultrasonography (54%, 88%, respectively). The sensitivity and positive predictive value of sestamibi with pertechnetate and ultrasonography did not differ in patients with thyroid nodules. Seventeen patients (15%) had discordant laterality on preoperative imaging. In discordant cases, sestamibi with pertechnetate was correct in 53% overall but in only 17% of those with thyroiditis (P = .01), whereas ultrasonography was correct in 26% overall but in 50% of those with thyroiditis (P = .01). CONCLUSION: Thyroiditis decreased the sensitivity and positive predictive value of sestamibi with pertechnetate in primary hyperparathyroidism. In patients with discordant laterality on preoperative imaging, sestamibi with pertechnetate is the more accurate choice to guide operative planning, although ultrasonography may be a better guide in those with thyroiditis.
引用
- Beck AC, Kashyap AK, Lal G, et al. Discordant findings on preoperative imaging for primary hyperparathyroidism and thyroid disease: Choosing the path to follow. Surgery. 2019. PMID: 31466855. doi:10.1016/j.surg.2019.05.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。